Glutaredoxin 2 (Grx2) gene deletion induces early onset of age-dependent cataracts in mice.
Identifieur interne : 000655 ( Main/Exploration ); précédent : 000654; suivant : 000656Glutaredoxin 2 (Grx2) gene deletion induces early onset of age-dependent cataracts in mice.
Auteurs : Hongli Wu [États-Unis] ; Yibo Yu [République populaire de Chine] ; Larry David [États-Unis] ; Ye-Shih Ho ; Marjorie F. Lou [États-Unis]Source :
- The Journal of biological chemistry [ 1083-351X ] ; 2014.
Descripteurs français
- KwdFr :
- Adénosine triphosphate (métabolisme), Animaux (MeSH), Capsule du cristallin (anatomopathologie), Capsule du cristallin (métabolisme), Cataracte (génétique), Complexe I de la chaîne respiratoire (métabolisme), Complexe IV de la chaîne respiratoire (métabolisme), Cystine (métabolisme), Délétion de gène (MeSH), Glutarédoxines (génétique), Glutathion (métabolisme), Mâle (MeSH), Protéines de l'oeil (métabolisme), Souris de souche-129 (MeSH), Souris knockout (MeSH).
- MESH :
- anatomopathologie : Capsule du cristallin.
- génétique : Cataracte, Glutarédoxines.
- métabolisme : Adénosine triphosphate, Capsule du cristallin, Complexe I de la chaîne respiratoire, Complexe IV de la chaîne respiratoire, Cystine, Glutathion, Protéines de l'oeil.
- Animaux, Délétion de gène, Mâle, Souris de souche-129, Souris knockout.
English descriptors
- KwdEn :
- Adenosine Triphosphate (metabolism), Animals (MeSH), Cataract (genetics), Cystine (metabolism), Electron Transport Complex I (metabolism), Electron Transport Complex IV (metabolism), Eye Proteins (metabolism), Gene Deletion (MeSH), Glutaredoxins (genetics), Glutathione (metabolism), Lens Capsule, Crystalline (metabolism), Lens Capsule, Crystalline (pathology), Male (MeSH), Mice, 129 Strain (MeSH), Mice, Knockout (MeSH).
- MESH :
- chemical , genetics : Glutaredoxins.
- chemical , metabolism : Adenosine Triphosphate, Cystine, Electron Transport Complex I, Electron Transport Complex IV, Eye Proteins, Glutathione.
- genetics : Cataract.
- metabolism : Lens Capsule, Crystalline.
- pathology : Lens Capsule, Crystalline.
- Animals, Gene Deletion, Male, Mice, 129 Strain, Mice, Knockout.
Abstract
Glutaredoxin 2 (Grx2) is an isozyme of glutaredoxin1 (thioltransferase) present in the mitochondria and nucleus with disulfide reductase and peroxidase activities, and it controls thiol/disulfide balance in cells. In this study, we investigated whether Grx2 gene deletion could induce faster age-related cataract formation and elucidated the biochemical changes effected by Grx2 gene deletion that may contribute to lens opacity. Slit lamp was used to examine the lenses in Grx2 knock-out (KO) mice and age-matched wild-type (WT) mice ages 1 to 16 months. In the Grx2 null mice, the lens nuclear opacity began at 5 months, 3 months sooner than that of the control mice, and the progression of cataracts was also much faster than the age-matched controls. Lenses of KO mice contained lower levels of protein thiols and GSH with a significant accumulation of S-glutathionylated proteins. Actin, αA-crystallin, and βB2-crystallin were identified by Western blot and mass spectroscopy as the major S-glutathionylated proteins in the lenses of 16-month-old Grx2 KO mice. Compared with the WT control, the lens of Grx2 KO mice had only 50% of the activity in complex I and complex IV and less than 10% of the ATP pool. It was concluded that Grx2 gene deletion altered the function of lens structural proteins through S-glutathionylation and also caused severe disturbance in mitochondrial function. These combined alterations affected lens transparency.
DOI: 10.1074/jbc.M114.620047
PubMed: 25362663
PubMed Central: PMC4276876
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Glutaredoxin 2 (Grx2) gene deletion induces early onset of age-dependent cataracts in mice.</title>
<author><name sortKey="Wu, Hongli" sort="Wu, Hongli" uniqKey="Wu H" first="Hongli" last="Wu">Hongli Wu</name>
<affiliation wicri:level="2"><nlm:affiliation>From the School of Veterinary Medicine and Biomedical Sciences, Redox Biology Center, University of Nebraska-Lincoln, Lincoln, Nebraska 68583, the Department of Pharmaceutical Sciences, College of Pharmacy, University of North Texas Health Science Center, Fort Worth, Texas 76107.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Texas</region>
</placeName>
<wicri:cityArea>From the School of Veterinary Medicine and Biomedical Sciences, Redox Biology Center, University of Nebraska-Lincoln, Lincoln, Nebraska 68583, the Department of Pharmaceutical Sciences, College of Pharmacy, University of North Texas Health Science Center, Fort Worth</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Yu, Yibo" sort="Yu, Yibo" uniqKey="Yu Y" first="Yibo" last="Yu">Yibo Yu</name>
<affiliation wicri:level="1"><nlm:affiliation>From the School of Veterinary Medicine and Biomedical Sciences, Redox Biology Center, University of Nebraska-Lincoln, Lincoln, Nebraska 68583, the Department of Ophthalmology, Eye Center of the 2nd Affiliated Hospital, Medical College of Zhejiang University, Hangzhou 310009, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>From the School of Veterinary Medicine and Biomedical Sciences, Redox Biology Center, University of Nebraska-Lincoln, Lincoln, Nebraska 68583, the Department of Ophthalmology, Eye Center of the 2nd Affiliated Hospital, Medical College of Zhejiang University, Hangzhou 310009</wicri:regionArea>
<placeName><settlement type="city">Hangzhou</settlement>
<region type="province">Zhejiang</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="David, Larry" sort="David, Larry" uniqKey="David L" first="Larry" last="David">Larry David</name>
<affiliation wicri:level="2"><nlm:affiliation>the Department of Biochemistry and Molecular Biology, Oregon Health and Science University, Portland, Oregon 97239.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Oregon</region>
</placeName>
<wicri:cityArea>the Department of Biochemistry and Molecular Biology, Oregon Health and Science University, Portland</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Ho, Ye Shih" sort="Ho, Ye Shih" uniqKey="Ho Y" first="Ye-Shih" last="Ho">Ye-Shih Ho</name>
<affiliation><nlm:affiliation>the Institute of Environment Health Sciences, Wayne State University, Detroit, Michigan 48201, and.</nlm:affiliation>
<wicri:noCountry code="subField">and</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Lou, Marjorie F" sort="Lou, Marjorie F" uniqKey="Lou M" first="Marjorie F" last="Lou">Marjorie F. Lou</name>
<affiliation wicri:level="1"><nlm:affiliation>From the School of Veterinary Medicine and Biomedical Sciences, Redox Biology Center, University of Nebraska-Lincoln, Lincoln, Nebraska 68583, the Department of Ophthalmology, University of Nebraska Medical Center, Omaha, Nebraska 698583 mlou1@unl.edu.</nlm:affiliation>
<country wicri:rule="url">États-Unis</country>
<wicri:regionArea>From the School of Veterinary Medicine and Biomedical Sciences, Redox Biology Center, University of Nebraska-Lincoln, Lincoln, Nebraska 68583, the Department of Ophthalmology, University of Nebraska Medical Center, Omaha</wicri:regionArea>
<wicri:noRegion>Omaha</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2014">2014</date>
<idno type="RBID">pubmed:25362663</idno>
<idno type="pmid">25362663</idno>
<idno type="doi">10.1074/jbc.M114.620047</idno>
<idno type="pmc">PMC4276876</idno>
<idno type="wicri:Area/Main/Corpus">000584</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000584</idno>
<idno type="wicri:Area/Main/Curation">000584</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000584</idno>
<idno type="wicri:Area/Main/Exploration">000584</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Glutaredoxin 2 (Grx2) gene deletion induces early onset of age-dependent cataracts in mice.</title>
<author><name sortKey="Wu, Hongli" sort="Wu, Hongli" uniqKey="Wu H" first="Hongli" last="Wu">Hongli Wu</name>
<affiliation wicri:level="2"><nlm:affiliation>From the School of Veterinary Medicine and Biomedical Sciences, Redox Biology Center, University of Nebraska-Lincoln, Lincoln, Nebraska 68583, the Department of Pharmaceutical Sciences, College of Pharmacy, University of North Texas Health Science Center, Fort Worth, Texas 76107.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Texas</region>
</placeName>
<wicri:cityArea>From the School of Veterinary Medicine and Biomedical Sciences, Redox Biology Center, University of Nebraska-Lincoln, Lincoln, Nebraska 68583, the Department of Pharmaceutical Sciences, College of Pharmacy, University of North Texas Health Science Center, Fort Worth</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Yu, Yibo" sort="Yu, Yibo" uniqKey="Yu Y" first="Yibo" last="Yu">Yibo Yu</name>
<affiliation wicri:level="1"><nlm:affiliation>From the School of Veterinary Medicine and Biomedical Sciences, Redox Biology Center, University of Nebraska-Lincoln, Lincoln, Nebraska 68583, the Department of Ophthalmology, Eye Center of the 2nd Affiliated Hospital, Medical College of Zhejiang University, Hangzhou 310009, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>From the School of Veterinary Medicine and Biomedical Sciences, Redox Biology Center, University of Nebraska-Lincoln, Lincoln, Nebraska 68583, the Department of Ophthalmology, Eye Center of the 2nd Affiliated Hospital, Medical College of Zhejiang University, Hangzhou 310009</wicri:regionArea>
<placeName><settlement type="city">Hangzhou</settlement>
<region type="province">Zhejiang</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="David, Larry" sort="David, Larry" uniqKey="David L" first="Larry" last="David">Larry David</name>
<affiliation wicri:level="2"><nlm:affiliation>the Department of Biochemistry and Molecular Biology, Oregon Health and Science University, Portland, Oregon 97239.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Oregon</region>
</placeName>
<wicri:cityArea>the Department of Biochemistry and Molecular Biology, Oregon Health and Science University, Portland</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Ho, Ye Shih" sort="Ho, Ye Shih" uniqKey="Ho Y" first="Ye-Shih" last="Ho">Ye-Shih Ho</name>
<affiliation><nlm:affiliation>the Institute of Environment Health Sciences, Wayne State University, Detroit, Michigan 48201, and.</nlm:affiliation>
<wicri:noCountry code="subField">and</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Lou, Marjorie F" sort="Lou, Marjorie F" uniqKey="Lou M" first="Marjorie F" last="Lou">Marjorie F. Lou</name>
<affiliation wicri:level="1"><nlm:affiliation>From the School of Veterinary Medicine and Biomedical Sciences, Redox Biology Center, University of Nebraska-Lincoln, Lincoln, Nebraska 68583, the Department of Ophthalmology, University of Nebraska Medical Center, Omaha, Nebraska 698583 mlou1@unl.edu.</nlm:affiliation>
<country wicri:rule="url">États-Unis</country>
<wicri:regionArea>From the School of Veterinary Medicine and Biomedical Sciences, Redox Biology Center, University of Nebraska-Lincoln, Lincoln, Nebraska 68583, the Department of Ophthalmology, University of Nebraska Medical Center, Omaha</wicri:regionArea>
<wicri:noRegion>Omaha</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j">The Journal of biological chemistry</title>
<idno type="eISSN">1083-351X</idno>
<imprint><date when="2014" type="published">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adenosine Triphosphate (metabolism)</term>
<term>Animals (MeSH)</term>
<term>Cataract (genetics)</term>
<term>Cystine (metabolism)</term>
<term>Electron Transport Complex I (metabolism)</term>
<term>Electron Transport Complex IV (metabolism)</term>
<term>Eye Proteins (metabolism)</term>
<term>Gene Deletion (MeSH)</term>
<term>Glutaredoxins (genetics)</term>
<term>Glutathione (metabolism)</term>
<term>Lens Capsule, Crystalline (metabolism)</term>
<term>Lens Capsule, Crystalline (pathology)</term>
<term>Male (MeSH)</term>
<term>Mice, 129 Strain (MeSH)</term>
<term>Mice, Knockout (MeSH)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adénosine triphosphate (métabolisme)</term>
<term>Animaux (MeSH)</term>
<term>Capsule du cristallin (anatomopathologie)</term>
<term>Capsule du cristallin (métabolisme)</term>
<term>Cataracte (génétique)</term>
<term>Complexe I de la chaîne respiratoire (métabolisme)</term>
<term>Complexe IV de la chaîne respiratoire (métabolisme)</term>
<term>Cystine (métabolisme)</term>
<term>Délétion de gène (MeSH)</term>
<term>Glutarédoxines (génétique)</term>
<term>Glutathion (métabolisme)</term>
<term>Mâle (MeSH)</term>
<term>Protéines de l'oeil (métabolisme)</term>
<term>Souris de souche-129 (MeSH)</term>
<term>Souris knockout (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>Glutaredoxins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Adenosine Triphosphate</term>
<term>Cystine</term>
<term>Electron Transport Complex I</term>
<term>Electron Transport Complex IV</term>
<term>Eye Proteins</term>
<term>Glutathione</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Capsule du cristallin</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Cataract</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>Cataracte</term>
<term>Glutarédoxines</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>Lens Capsule, Crystalline</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Adénosine triphosphate</term>
<term>Capsule du cristallin</term>
<term>Complexe I de la chaîne respiratoire</term>
<term>Complexe IV de la chaîne respiratoire</term>
<term>Cystine</term>
<term>Glutathion</term>
<term>Protéines de l'oeil</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Lens Capsule, Crystalline</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Animals</term>
<term>Gene Deletion</term>
<term>Male</term>
<term>Mice, 129 Strain</term>
<term>Mice, Knockout</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Animaux</term>
<term>Délétion de gène</term>
<term>Mâle</term>
<term>Souris de souche-129</term>
<term>Souris knockout</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Glutaredoxin 2 (Grx2) is an isozyme of glutaredoxin1 (thioltransferase) present in the mitochondria and nucleus with disulfide reductase and peroxidase activities, and it controls thiol/disulfide balance in cells. In this study, we investigated whether Grx2 gene deletion could induce faster age-related cataract formation and elucidated the biochemical changes effected by Grx2 gene deletion that may contribute to lens opacity. Slit lamp was used to examine the lenses in Grx2 knock-out (KO) mice and age-matched wild-type (WT) mice ages 1 to 16 months. In the Grx2 null mice, the lens nuclear opacity began at 5 months, 3 months sooner than that of the control mice, and the progression of cataracts was also much faster than the age-matched controls. Lenses of KO mice contained lower levels of protein thiols and GSH with a significant accumulation of S-glutathionylated proteins. Actin, αA-crystallin, and βB2-crystallin were identified by Western blot and mass spectroscopy as the major S-glutathionylated proteins in the lenses of 16-month-old Grx2 KO mice. Compared with the WT control, the lens of Grx2 KO mice had only 50% of the activity in complex I and complex IV and less than 10% of the ATP pool. It was concluded that Grx2 gene deletion altered the function of lens structural proteins through S-glutathionylation and also caused severe disturbance in mitochondrial function. These combined alterations affected lens transparency. </div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25362663</PMID>
<DateCompleted><Year>2015</Year>
<Month>04</Month>
<Day>14</Day>
</DateCompleted>
<DateRevised><Year>2019</Year>
<Month>12</Month>
<Day>10</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1083-351X</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>289</Volume>
<Issue>52</Issue>
<PubDate><Year>2014</Year>
<Month>Dec</Month>
<Day>26</Day>
</PubDate>
</JournalIssue>
<Title>The Journal of biological chemistry</Title>
<ISOAbbreviation>J Biol Chem</ISOAbbreviation>
</Journal>
<ArticleTitle>Glutaredoxin 2 (Grx2) gene deletion induces early onset of age-dependent cataracts in mice.</ArticleTitle>
<Pagination><MedlinePgn>36125-39</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1074/jbc.M114.620047</ELocationID>
<Abstract><AbstractText>Glutaredoxin 2 (Grx2) is an isozyme of glutaredoxin1 (thioltransferase) present in the mitochondria and nucleus with disulfide reductase and peroxidase activities, and it controls thiol/disulfide balance in cells. In this study, we investigated whether Grx2 gene deletion could induce faster age-related cataract formation and elucidated the biochemical changes effected by Grx2 gene deletion that may contribute to lens opacity. Slit lamp was used to examine the lenses in Grx2 knock-out (KO) mice and age-matched wild-type (WT) mice ages 1 to 16 months. In the Grx2 null mice, the lens nuclear opacity began at 5 months, 3 months sooner than that of the control mice, and the progression of cataracts was also much faster than the age-matched controls. Lenses of KO mice contained lower levels of protein thiols and GSH with a significant accumulation of S-glutathionylated proteins. Actin, αA-crystallin, and βB2-crystallin were identified by Western blot and mass spectroscopy as the major S-glutathionylated proteins in the lenses of 16-month-old Grx2 KO mice. Compared with the WT control, the lens of Grx2 KO mice had only 50% of the activity in complex I and complex IV and less than 10% of the ATP pool. It was concluded that Grx2 gene deletion altered the function of lens structural proteins through S-glutathionylation and also caused severe disturbance in mitochondrial function. These combined alterations affected lens transparency. </AbstractText>
<CopyrightInformation>© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wu</LastName>
<ForeName>Hongli</ForeName>
<Initials>H</Initials>
<AffiliationInfo><Affiliation>From the School of Veterinary Medicine and Biomedical Sciences, Redox Biology Center, University of Nebraska-Lincoln, Lincoln, Nebraska 68583, the Department of Pharmaceutical Sciences, College of Pharmacy, University of North Texas Health Science Center, Fort Worth, Texas 76107.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Yu</LastName>
<ForeName>Yibo</ForeName>
<Initials>Y</Initials>
<AffiliationInfo><Affiliation>From the School of Veterinary Medicine and Biomedical Sciences, Redox Biology Center, University of Nebraska-Lincoln, Lincoln, Nebraska 68583, the Department of Ophthalmology, Eye Center of the 2nd Affiliated Hospital, Medical College of Zhejiang University, Hangzhou 310009, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>David</LastName>
<ForeName>Larry</ForeName>
<Initials>L</Initials>
<AffiliationInfo><Affiliation>the Department of Biochemistry and Molecular Biology, Oregon Health and Science University, Portland, Oregon 97239.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Ho</LastName>
<ForeName>Ye-Shih</ForeName>
<Initials>YS</Initials>
<AffiliationInfo><Affiliation>the Institute of Environment Health Sciences, Wayne State University, Detroit, Michigan 48201, and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Lou</LastName>
<ForeName>Marjorie F</ForeName>
<Initials>MF</Initials>
<AffiliationInfo><Affiliation>From the School of Veterinary Medicine and Biomedical Sciences, Redox Biology Center, University of Nebraska-Lincoln, Lincoln, Nebraska 68583, the Department of Ophthalmology, University of Nebraska Medical Center, Omaha, Nebraska 698583 mlou1@unl.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y"><Grant><GrantID>P30 EY010572</GrantID>
<Acronym>EY</Acronym>
<Agency>NEI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>R01 EY10595</GrantID>
<Acronym>EY</Acronym>
<Agency>NEI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>P30 ES06639</GrantID>
<Acronym>ES</Acronym>
<Agency>NIEHS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>P30 ES006639</GrantID>
<Acronym>ES</Acronym>
<Agency>NIEHS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>R01 EY010595</GrantID>
<Acronym>EY</Acronym>
<Agency>NEI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2014</Year>
<Month>11</Month>
<Day>01</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>J Biol Chem</MedlineTA>
<NlmUniqueID>2985121R</NlmUniqueID>
<ISSNLinking>0021-9258</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D005136">Eye Proteins</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C516009">Glrx2 protein, mouse</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D054477">Glutaredoxins</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>48TCX9A1VT</RegistryNumber>
<NameOfSubstance UI="D003553">Cystine</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>8L70Q75FXE</RegistryNumber>
<NameOfSubstance UI="D000255">Adenosine Triphosphate</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 1.9.3.1</RegistryNumber>
<NameOfSubstance UI="D003576">Electron Transport Complex IV</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 7.1.1.2</RegistryNumber>
<NameOfSubstance UI="D042967">Electron Transport Complex I</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>GAN16C9B8O</RegistryNumber>
<NameOfSubstance UI="D005978">Glutathione</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000255" MajorTopicYN="N">Adenosine Triphosphate</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002386" MajorTopicYN="N">Cataract</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003553" MajorTopicYN="N">Cystine</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D042967" MajorTopicYN="N">Electron Transport Complex I</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003576" MajorTopicYN="N">Electron Transport Complex IV</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005136" MajorTopicYN="N">Eye Proteins</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D017353" MajorTopicYN="N">Gene Deletion</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D054477" MajorTopicYN="N">Glutaredoxins</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005978" MajorTopicYN="N">Glutathione</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007903" MajorTopicYN="N">Lens Capsule, Crystalline</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D057507" MajorTopicYN="N">Mice, 129 Strain</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018345" MajorTopicYN="N">Mice, Knockout</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Age-related Cataract</Keyword>
<Keyword MajorTopicYN="N">Electron Transport System</Keyword>
<Keyword MajorTopicYN="N">Glutaredoxin 2</Keyword>
<Keyword MajorTopicYN="N">Oxidative Stress</Keyword>
<Keyword MajorTopicYN="N">α-Crystallin Protein</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year>
<Month>11</Month>
<Day>3</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2014</Year>
<Month>11</Month>
<Day>5</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2015</Year>
<Month>4</Month>
<Day>15</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">25362663</ArticleId>
<ArticleId IdType="pii">M114.620047</ArticleId>
<ArticleId IdType="doi">10.1074/jbc.M114.620047</ArticleId>
<ArticleId IdType="pmc">PMC4276876</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Exp Eye Res. 1996 Oct;63(4):433-41</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8944550</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Surv Ophthalmol. 2000 Sep-Oct;45(2):115-34</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11033038</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Free Radic Biol Med. 2011 Dec 1;51(11):2108-17</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21983434</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 1993 Sep 15;90(18):8424-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8378314</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Rev Drug Discov. 2004 Mar;3(3):205-14</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15031734</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Biol Chem. 2004 Nov 12;279(46):47939-51</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15347644</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochem Biophys Res Commun. 2005 Feb 18;327(3):774-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15649413</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 1978 Jul;75(7):3244-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">277922</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Stroke. 1979 Jul-Aug;10(4):437-46</Citation>
<ArticleIdList><ArticleId IdType="pubmed">505482</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Exp Eye Res. 2000 Jun;70(6):745-53</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10843779</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Exp Eye Res. 2005 Sep;81(3):276-85</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16129095</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Free Radic Biol Med. 2007 Nov 1;43(9):1299-312</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17893043</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>FEBS Lett. 1983 Feb 7;152(1):114-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">6840271</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Biol Chem. 2001 Aug 10;276(32):30374-80</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11397793</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Exp Eye Res. 1983 Jan;36(1):15-23</Citation>
<ArticleIdList><ArticleId IdType="pubmed">6825728</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2005 Jun 7;102(23):8168-73</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15917333</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Biol Chem. 2001 Jul 13;276(28):26269-75</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11297543</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Curr Opin Pharmacol. 2007 Aug;7(4):381-91</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17662654</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell. 2001 Jan 26;104(2):173-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11207359</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Invest Ophthalmol Vis Sci. 2008 Oct;49(10):4497-505</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18586881</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 2000 Nov 9;408(6809):239-47</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11089981</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Antioxid Redox Signal. 2005 Mar-Apr;7(3-4):348-66</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15706083</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Exp Eye Res. 2002 Jan;74(1):113-22</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11878824</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Antioxid Redox Signal. 2008 Nov;10(11):1941-88</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18774901</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochim Biophys Acta. 2010 Oct;1797(10):1705-15</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20547138</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Biol Chem. 1999 Feb 19;274(8):4735-42</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9988710</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell. 1991 Jun 28;65(7):1153-63</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2065352</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Exp Eye Res. 1988 Apr;46(4):517-30</Citation>
<ArticleIdList><ArticleId IdType="pubmed">3133235</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Exp Eye Res. 1999 May;68(5):547-52</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10328968</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Biol Chem. 2013 Mar 22;288(12):8365-79</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23335511</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Invest Ophthalmol Vis Sci. 2005 Oct;46(10):3783-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16186363</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Biol Chem. 1997 Nov 14;272(46):29099-103</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9360985</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Exp Eye Res. 1992 Dec;55(6):889-96</Citation>
<ArticleIdList><ArticleId IdType="pubmed">1486943</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Invest Ophthalmol Vis Sci. 2003 Aug;44(8):3263-71</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12882768</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>FASEB J. 2006 Dec;20(14):2645-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17065220</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Br J Ophthalmol. 2001 Mar;85(3):261-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11222327</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Biol Chem. 1989 Aug 25;264(24):13963-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2668278</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Ann Neurol. 2003;53 Suppl 3:S26-36; discussion S36-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12666096</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Mol Biol Cell. 2010 Jun 15;21(12):1945-54</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20427569</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Ocul Biol Dis Infor. 2009 Dec 12;2(4):223-234</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20157357</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Exp Eye Res. 1986 Jun;42(6):607-16</Citation>
<ArticleIdList><ArticleId IdType="pubmed">3720875</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Exp Eye Res. 1988 Jul;47(1):17-25</Citation>
<ArticleIdList><ArticleId IdType="pubmed">3409984</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Prog Retin Eye Res. 2003 Sep;22(5):657-82</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12892645</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochemistry. 1990 Jan 16;29(2):464-70</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2302385</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Invest Ophthalmol Vis Sci. 2004 Jan;45(1):230-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14691178</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Exp Eye Res. 1977 Aug;25(2):139-48</Citation>
<ArticleIdList><ArticleId IdType="pubmed">913506</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Exp Eye Res. 2015 Jan;130:58-65</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25479045</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):3913-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12655060</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>FASEB J. 1995 Sep;9(12):1173-82</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7672510</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Curr Eye Res. 1989 Sep;8(9):883-90</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2791632</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochem J. 1980 Jul 15;190(1):125-30</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7447929</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Biol Chem. 2013 Sep 13;288(37):26497-504</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23861399</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Chem. 2007 Apr;53(4):729-34</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17332151</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Antioxid Redox Signal. 2007 Nov;9(11):2027-33</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17845131</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Arch Ophthalmol. 1989 Jul;107(7):991-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2751471</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>République populaire de Chine</li>
<li>États-Unis</li>
</country>
<region><li>Oregon</li>
<li>Texas</li>
<li>Zhejiang</li>
</region>
<settlement><li>Hangzhou</li>
</settlement>
</list>
<tree><noCountry><name sortKey="Ho, Ye Shih" sort="Ho, Ye Shih" uniqKey="Ho Y" first="Ye-Shih" last="Ho">Ye-Shih Ho</name>
</noCountry>
<country name="États-Unis"><region name="Texas"><name sortKey="Wu, Hongli" sort="Wu, Hongli" uniqKey="Wu H" first="Hongli" last="Wu">Hongli Wu</name>
</region>
<name sortKey="David, Larry" sort="David, Larry" uniqKey="David L" first="Larry" last="David">Larry David</name>
<name sortKey="Lou, Marjorie F" sort="Lou, Marjorie F" uniqKey="Lou M" first="Marjorie F" last="Lou">Marjorie F. Lou</name>
</country>
<country name="République populaire de Chine"><region name="Zhejiang"><name sortKey="Yu, Yibo" sort="Yu, Yibo" uniqKey="Yu Y" first="Yibo" last="Yu">Yibo Yu</name>
</region>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Bois/explor/GlutaredoxinV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000655 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000655 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Bois |area= GlutaredoxinV1 |flux= Main |étape= Exploration |type= RBID |clé= pubmed:25362663 |texte= Glutaredoxin 2 (Grx2) gene deletion induces early onset of age-dependent cataracts in mice. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:25362663" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a GlutaredoxinV1
This area was generated with Dilib version V0.6.37. |